Sacral Neuromodulation For Overactive Bladder

Sacral Neuromodulation For Overactive Bladder

When test stimulation demonstrates sufficient improvement and the clinical team confirms suitability, the permanent neurostimulator is implanted under the skin.
Send Inquiry
Description
Technical Parameters

1. When to Consider Sacral Neuromodulation for Overactive Bladder

SNM may be considered for patients with persistent OAB symptoms despite previous treatment.

Relevant symptoms include:

  • Urinary urgency that is difficult to control.
  • Frequent daytime urination.
  • Nocturia that interrupts sleep.
  • Urge urinary incontinence.
  • Persistent symptoms despite behavioral therapy and medication.

An OAB diagnosis alone does not establish eligibility for SNM. Patient selection requires an individual clinical assessment of symptom severity, previous treatments, medical history and other possible causes of urinary symptoms.

2. Patient Evaluation and Test Stimulation

The treatment pathway includes an assessment stage before permanent implantation.

For international patients, preliminary medical record reviews can be arranged remotely. Relevant materials include:

  • Previous diagnosis and treatment records.
  • Urinary symptom history.
  • Urodynamic study reports, when available.
  • Ultrasound and other relevant imaging.
  • Current medication and previous treatment information.

Further in-person evaluation may be required before treatment.

Two-stage treatment process

Stage Procedure Specific details
Stage 1 Temporary electrode placement Electrode positioned near the sacral nerve under local anesthesia
Test stimulation External stimulation Approximately 2 weeks
Placement guidance Fluoroscopic guidance Used during temporary electrode placement
Procedure duration Test electrode placement Approximately 1 hour
Stage 2 Permanent implantation Considered when test stimulation achieves at least 50% symptom improvement

During the test phase, a temporary electrode delivers stimulation through an external stimulator. The patient's symptom response is assessed before permanent implantation is considered. Patients who do not achieve the required improvement need further clinical review rather than automatic progression to permanent implantation.

3. Permanent Implantation and Treatment Management

When test stimulation demonstrates sufficient improvement and the clinical team confirms suitability, the permanent neurostimulator is implanted under the skin.

The implanted sacral neuromodulation system delivers electrical stimulation to the sacral nerves. Stimulation parameters can be adjusted through device programming during follow-up care.

The treatment pathway includes:

  • Review of test stimulation results.
  • Confirmation of suitability for permanent implantation.
  • Permanent neurostimulator implantation.
  • Initial device programming.
  • Follow-up assessment and parameter adjustments when required.

Individual symptom improvement and long-term outcomes vary. Potential complications, including infection, implant-site pain, lead displacement and possible revision surgery, should be discussed during clinical consultation.

4. Available Implantable Neurostimulator Options

Three implantable neurostimulator configurations are listed in our website's treatment information. Their main differences concern battery type, battery life, device weight, volume and charging requirements.

Feature G132 G131 G134R
Battery type Non-rechargeable Non-rechargeable Rechargeable
Battery life 6–8 years 8–11 years 20+ years
Weight 25 g 35 g 36 g
Volume Smallest Medium Medium
Battery capacity 1850 mAh 2500 mAh Not specified
Stimulation parameters 0–10 V / 0–25 mA 0–10 V / 0–25 mA 0–10 V / 0–25 mA
Charging requirements No routine charging No routine charging Wireless charging approximately every 2–3 months
MRI compatibility stated on the website 1.5T and 3.0T 1.5T and 3.0T 1.5T and 3.0T

Device configuration differences

  • G132: The smallest listed volume, a weight of 25 g and a non-rechargeable battery with a stated life of 6–8 years.
  • G131: A non-rechargeable configuration weighing 35 g, with a stated battery life of 8–11 years and a capacity of 2500 mAh.
  • G134R: A rechargeable configuration weighing 36 g, with a stated battery life of more than 20 years and wireless charging approximately every 2–3 months.

The appropriate configuration depends on the patient's clinical condition, stimulation requirements, lifestyle and preferences. Battery-life figures are published specifications, not guarantees of actual service life. MRI examinations must be assessed against the applicable device labeling and scanning conditions.

5. International Patient Assessment and Follow-Up

Our website describes international patient support covering preliminary assessment, treatment coordination and follow-up.

Remote medical record review

International patients can submit imaging, urodynamic studies and previous medical records for preliminary assessment. The clinical team can review treatment history and determine whether further in-person evaluation is appropriate.

English-language medical communication

English-language medical communication is available for consultations, treatment explanations and care instructions.

Remote programming

After treatment and return to their home country, eligible patients can receive remote device programming support through the clinical service. Availability depends on the implanted system, technical arrangements and applicable local requirements.

Continuous follow-up

Follow-up support includes recovery-related communication, device adjustment when required and annual check-ins. Individual follow-up schedules depend on clinical needs.

6. Clinical Experience and Multidisciplinary Support

The clinical profile presented on our website includes Dr. Zhang Yifei, whose experience and professional background are central to the described SNM treatment program.

Published clinical information includes:

  • More than 30 years of experience in urinary control disorders and related clinical practice.
  • More than 1,000 SNM procedures performed.
  • Experience in urology, neuro-urology and complex urinary dysfunction.
  • Leadership of a multidisciplinary team involving urologists, neuro-urologists and rehabilitation specialists.

This multidisciplinary approach supports the assessment of patients with overlapping urinary and neurological conditions, particularly when previous treatment has not provided sufficient symptom relief.

7. Request an Overactive Bladder Treatment Assessment

If you have persistent urinary urgency, frequency or urge incontinence despite previous treatment, submit your available medical records for an initial SNM assessment.

Send your diagnostic reports, urodynamic results, imaging and a brief summary of previous treatments. The clinical team can review the information and advise whether further evaluation for sacral neuromodulation is appropriate.

A remote assessment is preliminary and does not replace an in-person diagnosis or guarantee eligibility for surgery. Individual treatment recommendations depend on clinical findings and the patient's response to evaluation.

Start your medical assessment

Submit your available medical records to the international patient team to request an initial assessment.

Submit Your Medical Records

 

Hot Tags: sacral neuromodulation for overactive bladder, China, price, pricelist, quotation, cost, clinician programmer neurostimulator, Indications For Sacral Neuromodulation, sacral nerve stimulation test lead, sacral neuromodulation charger, sacral neuromodulation programmer, tined sacral lead

Send Inquiry
Send Inquiry